Ora Biomedical, Inc. — Form D
Ora Biomedical, Inc. of Tukwila, WA, a company, filed a Form D exempt-offering notice with the SEC on 2024-01-26. The offering totals $1.0M, of which $720K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-01-26
- Form: D
- Accession: 0001927878-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $720K
- Remaining: $300K
- Investors: 6
- Date of first sale: 2024-01-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-503534
Issuer
- Name: Ora Biomedical, Inc.
- CIK: 0001927878
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 12101 Tukwila International Blvd, Tukwila, WA, 98168
- Phone: 206-839-6250
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Matthew Kaeberlein | Director | Tukwila, WA |
| Mitchell Lee | Director | Tukwila, WA |
| John Sabey | Director | Austin, TX |
| Mitchell Lee | Executive Officer | Tukwila, WA |
| Matthew Kaeberlein | Promoter | Tukwila, WA |
| Mitchell Lee | Promoter | Tukwila, WA |
| Mitchell Brendon Lee | Executive Officer | North Bend, WA |
| Mitchell Brendon Lee | Promoter | North Bend, WA |
Other filings by this issuer (1)
More